Author:
Morris Elana,Teplinskaya Anna,Olansky Evelyn,Rinderle Jeffrey Kemp,Chapin-Bardales Johanna, , ,Barak Narquis,Brady Kathleen A.,Braunstein Sarah,Davis Jasmine,Glick Sara,Harrington Andrea,Lopez Jasmine,Ma Yingbo,Martin Aleks,Mustaafaa Genetha,Nassau Tanner,Olaes Gia,Reuer Jennifer,Rivera Alexis,Robinson William T.,Sey Ekow Kwa,Sicro Sofia,Taylor Brittany,Trujillo Dillon,Wilson Erin,Wortley Pascale
Publisher
Centers for Disease Control MMWR Office
Reference36 articles.
1. CDC. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update: a clinical practice guideline. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
2. Ending the HIV epidemic.;Fauci;JAMA,2019
3. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.;Grant;N Engl J Med,2010
4. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.;Grohskopf;J Acquir Immune Defic Syndr,2013
5. Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.;Cooney;Ann Epidemiol,2022